Belvedere Trading LLC Tcr2 Therapeutics Inc. Call Options Transaction History

Belvedere Trading LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	BUY	$0.83 - $1.44 $166 - $288	200 Added 0.34%	59,500 $59,000
Q3 2022 Oct 26, 2022	SELL	$1.86 - $3.75 $14,322 - $28,875	-7,700 Reduced 11.49%	59,300 $96,000
Q2 2022 Jul 21, 2022	BUY	$2.11 - $2.94 $141,370 - $196,980	67,000 New	67,000 $222,000
Q1 2021 Apr 27, 2021	SELL	$20.38 - $34.07 $40,760 - $68,140	-2,000 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$19.0 - $32.63 $38,000 - $65,260	2,000 New	2,000 $62,000

Ticker TCRR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,606,400
Description
TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. The company's lead product candidates include gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which is in phase I/II clinical tria...

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Belvedere Trading LLC with notifications on news.